Recce Pharmaceuticals Sponsored Session: Beyond Existing Antibiotics: Finding a Solution to AMR and Sepsis

4.82 (38 votes)

Description: 

Date/Time: April 10, 2024 | 11:50 am - 12:20 pm ET

Beyond Existing Antibiotics: Finding a Solution to AMR and Sepsis will be an exploration into the forefront of medical innovation. In this sponsored session, Recce Pharmaceuticals unveils their portfolio approach to tackling the growing threats of antimicrobial resistance (AMR) and sepsis, two critical challenges in modern healthcare. Through innovative synthetic anti-infectives, Recce's breakthrough clinical-stage technology aims to go beyond conventional antibiotics, offering a novel, broad-spectrum solution to combatting resistant strains of bacteria and addressing the urgent need for effective sepsis treatments.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

James Graham

Managing Director & Chief Executive Officer

Recce Pharmaceuticals

James Graham is the Chief Executive Officer of Recce Pharmaceuticals. He was formerly the Executive Director and has extensive experience in marketing, business development, and commercialization of early-stage technologies with global potential. Mr. Graham has served on Recce’s Board of Directors for six years and has invested in almost every capital raise to date with a focus on expanding Recce’s commercial opportunities and clinical initiatives.

Components visible upon registration.